Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.

Abstract

BACKGROUND Sclerosing cutaneous neoplasms often represent a diagnostic challenge. The monoclonal antibody Ber-EP4 recognizes two glycopolypeptides found in most human epithelial cells. It is diagnostically highly reliable in the differentiation between basal cell carcinoma and cutaneous squamous cell carcinoma. In this study, we report its application in… (More)

Topics

Cite this paper

@article{Krahl2007MonoclonalAB, title={Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.}, author={Dieter Krahl and Klaus Sellheyer}, journal={Journal of cutaneous pathology}, year={2007}, volume={34 10}, pages={782-7} }